Here are 10 more things that piqued our interest at HBI 2019, where sector stakeholders from payors to investors come together to grapple with the biggest and most interesting issues of the year.
When it comes to competition between the public sector and private operators in healthcare, the playing field is seldom even. Interestingly, however, the roles of David and Goliath in this particular matchup are often reversed depending on which country you look at, the extent to which public services are state-funded, and whether legislation is a help or a hindrance. Public and private are not, however, the only options.
This week delegates from around the world descended on London for HBI 2019 to discuss the healthcare market and its various sub-sectors. Here are the things we learnt:
The good news is it is now crystal clear what the winning business models are. The bad news is that no one has worked out how to negotiate the silos. Next week the global for-profit health care sector meets at HBI 2019 in London: What is the main theme?
Ramsay Generale de Sante has revealed just €20m of synergies will be gained from its Capio deal, or around 1.8% of the deal value, highlighting the lower synergies accruable in the hospital sector compared with other sectors where the synergy-to-valuation ratio can be twice as high. Ramsay Generale de Sante’s second, successful offer for the […]
The world is facing a global healthcare workforce crisis. Technology is often cited as the universal panacea to this shortfall - but digital health companies are a long way away from being able to provide a solution - even if legislation allowed them to and the public was ready to fully embrace it.
Will technology and Universal Health Coverage prompt for-profits to try and bring affordable primary care to the uninsured mass markets, a sector those seeking returns routinely ignore?
You would hope that decisions about treatment pathways for patients are made with outcomes in mind – albeit tempered with the realism that having a finite budget brings to the table. This is not always the case.
People with complex mental health care needs require robust staffing and regulatory practices from domiciliary care providers. The UK is falling painfully short of such standards, with the BBC reporting an increase in serious injuries of 300% in the last eight years for residents with complex needs being cared for in the community. Such a rise is shocking and begs the question: If the UK can't manage it, can domiciliary care anywhere really meet the needs of such residents, and at what point do we decide when a patient should move to community care?
HBI has just finished a deep dive into the rehabilitation sector. This small, fragmented, poor relative of acute care is often ignored by operators. A perception of low margins and a reluctance among acute hospitals to refer on to rehab cannot be helping. But things are changing, and new markets are opening up.
Once a year, over 80,000 healthcare operators, providers and experts gather at Dubai's World Trade Centre for four days of Arab Health. According to suppliers, it's the event at which payors and providers begin to think about what they might like to purchase and where they might consider expanding.
A new scandal is erupting in the care home sector. A Nordic nursing home has been found to be falling far short of the standard of care its residents have the right to expect, and an angry public wants someone to blame. Yesterday, the CEO of Finland’s largest nursing home group by revenue fell on […]
A five-week pregnant woman in Singapore today can take out a S$79 insurance policy with MetLife to cover gestational diabetes (GDM). If 12-weeks later her blood glucose tests comes back positive, her nurse can input that affirmative data on the system and the patient is immediately sent S$500 from her insurer.
Primary care is one of Europe's most underdeveloped markets, despite many practices being owned and run as private businesses. Private equity has largely steered clear and the market is yet to find another consolidator. Reform is underway in parts of Europe giving patients more choice in primary care and outpatient settings, however - and this could disrupt the market.
As with any for-profit sector, entrepreneurs are the lifeblood of health care services, although they keep a particularly low profile in this industry - for obvious reasons.
When you talk to anyone about the MENA healthcare market, it’s very hard to steer the conversation away from Saudi Arabia. It’s awash with potential – but is the Khashoggi case having the cooling effect some in the region feared?
Swab your saliva, or extract some blood, and send it off in the post. In a few weeks, you can have a report suggesting what exercises you should do, how much coffee to drink, and your risk of developing metastatic breast cancer. There's a new wave of lifestyle/wellness/preventative health tests being sold B2B and B2C across the world. Could wellness genetics disrupt the market?
We map out 2018's international expansion - and retreat - by healthcare operators in one infographic. It reveals clear trends, like; which regions are the most attractive, where sluggish growth is forcing expansion abroad and which sectors are internationalising fastest. But many big players have also cut their losses in foreign markets this year, so was it, on balance, a positive year for proponents of international diversification?
Patients are notoriously protective over their health data, particularly where large tech firms are involved. That's because, up to now, few have encouraged them to release this data with financial rewards. Data, we hear, is the black oil of the healthcare industry and cryptocurrency could be the carrot that patients need.
The private sector likes to brag about how it can introduce superior quality to emerging market health systems so it's refreshing to have this confirmed by those without an interest. Especially in a country where the price paid to private operators has been called into question.
Google has a new man to lead its healthcare ventures, with experience in integrated care systems, electronic health records and genetics. At the same time, the US-tech giant has finally moved its UK-based healthcare data algorithm mining company over to its US HQ. Coincidence? We think not.
Donald Trump isn't the only president on the other side of the Atlantic to turn a nation's political landscape on its head. Brazil's new populist president, Jair Bolsonaro, shocked pundits the world over by bagging the presidency - and showed the world he can be as vitriolic as his US counterpart, too. But the business world likes him.
Integrated care remains an enigma across most of Europe despite the best (expensive) efforts of some - the UK's NHS infamously abandoned IT system cost £10bn alone (€11.5bn) in 2013. With the increasing adoption of telehealth, could this be about to change?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
